We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$4.29B
AUM Growth
+$1.24B
Cap. Flow
+$869M
Cap. Flow %
20.27%
Top 10 Hldgs %
32.29%
Holding
664
New
267
Increased
41
Reduced
55
Closed
201

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$84.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$79.5M
3
FSLR icon
First Solar
FSLR
+$66.4M
4
TWOU
2U Inc
TWOU
+$48.8M
5
CZR icon
Caesars Entertainment
CZR
+$43.9M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$104M
2
AAL icon
American Airlines Group
AAL
+$103M
3
OKE icon
Oneok
OKE
+$69.6M
4
TME icon
Tencent Music
TME
+$68.1M
5
PCG icon
PG&E
PCG
+$64.9M

Sector Composition

Rank Sector Weight
1 Technology 7.83%
2 Consumer Discretionary 6.31%
3 Healthcare 6.17%
4 Financials 3.16%
5 Consumer Staples 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
351
PUT
Freeport-McMoran
FCX
$99.8B
$816K 0.02%
+52,200
New +$753K
RAPT
352
DELISTED
RAPT Therapeutics
RAPT
$789K 0.02%
+3,061
New +$679K
CSX icon
353
CSX Corp
CSX
$94.7B
$777K 0.02%
+30,000
New +$740K
ANNX icon
354
Annexon
ANNX
$880M
$756K 0.02%
+25,000
New +$587K
ACTCU
355
DELISTED
ArcLight Clean Transition Corp. Unit
ACTCU
$753K 0.02%
+75,000
New +$752K
SBG.U
356
DELISTED
Sandbridge Acquisition Corporation Units, each consisting of one share of Class A Common Stock and o
SBG.U
$749K 0.02%
+75,000
New +$751K
XERS icon
357
CALL
Xeris Biopharma Holdings
XERS
$1.4B
$741K 0.02%
+125,000
New +$500K
ZSAN
358
DELISTED
Zosano Pharma Corporation
ZSAN
$734K 0.02%
+12,948
New +$603K
FUSN
359
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$702K 0.02%
58,398
-1,602
-3% -$21.9K
KLRS
360
Kalaris Therapeutics
KLRS
$99.7M
$688K 0.02%
+1,087
New +$742K
COST icon
361
CALL
Costco
COST
$418B
$675K 0.02%
1,900
-12,700
-87% -$4.27M
REGN icon
362
CALL
Regeneron Pharmaceuticals
REGN
$79.1B
$672K 0.02%
1,200
– –
TSHA icon
363
Taysha Gene Therapies
TSHA
$1.86B
$672K 0.02%
+30,000
New +$706K
VOD icon
364
Vodafone
VOD
$35.4B
$671K 0.02%
+50,000
New +$754K
GYRE icon
365
Gyre Therapeutics
GYRE
$695M
$670K 0.02%
20,769
-26,900
-56% -$1.05M
OMER icon
366
Omeros
OMER
$916M
$657K 0.02%
+64,973
New +$837K
ATNX
367
DELISTED
Athenex, Inc. Common Stock
ATNX
$653K 0.02%
+2,698
New +$648K
ORCL icon
368
Oracle
ORCL
$416B
$647K 0.02%
+10,831
New +$615K
DAL icon
369
Delta Air Lines
DAL
$61.3B
$642K 0.02%
+21,000
New +$606K
GILD icon
370
PUT
Gilead Sciences
GILD
$164B
$632K 0.01%
10,000
– –
FNV icon
371
Franco-Nevada
FNV
$43.7B
$628K 0.01%
+4,500
New +$669K
DGNR.U
372
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
$613K 0.01%
+50,000
New +$593K
GILD icon
373
CALL
Gilead Sciences
GILD
$164B
$600K 0.01%
9,500
– –
FDX icon
374
FedEx
FDX
$73.5B
$578K 0.01%
+2,300
New +$460K
PLRX icon
375
Pliant Therapeutics
PLRX
$65M
$566K 0.01%
25,000
– –
13 14
15
16 17

Similar funds

CIG
CCM Investment Group Northfield, Minnesota $946M AUM
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
SWC
Spectrum Wealth Counsel Indianapolis, Indiana $833M AUM 10.83% 1-Year Est. Return
KTA
Keeley-Teton Advisors Chicago, Illinois $825M AUM 5.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

CAAS Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, CAAS Capital Management held 664 positions worth $4.29B, up 41% from $3.04B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

CAAS Capital Management deployed $869M of net new capital in Q3 2020, opening 267 new positions and adding to 41 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 239,770 shares worth $80.3M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Match Group, an estimated $50.2M trimmed.

  • CAAS Capital Management's largest Q3 2020 buy was State Street SPDR S&P 500 ETF Trust: 239,770 shares worth $80.3M.
  • CAAS Capital Management added most to Keurig Dr Pepper in Q3 2020, an estimated $84.2M increase.
  • CAAS Capital Management's biggest Q3 2020 reduction was Match Group, cutting an estimated $50.2M.
  • CAAS Capital Management fully exited T-Mobile US in Q3 2020, selling an estimated $104M.
  • CAAS Capital Management's ten largest holdings make up 32% of its $4.29B portfolio in Q3 2020.
  • CAAS Capital Management opened 267 new positions and closed 201 in Q3 2020.
  • CAAS Capital Management's portfolio value rose 41% quarter-over-quarter to $4.29B.

Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.